|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||859.70 - 876.20|
|52-week range||281.15 - 1,023.10|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||17.01|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
An affiliate of New Mountain Capital, LLC ("New Mountain") announced the completion of its acquisition of Natrol, a leading vitamins, minerals and supplements brand, focused on sleep, mood & stress and brain health. New Mountain intends to combine Natrol with Jarrow Formulas ("Jarrow"), another New Mountain portfolio company.
New Mountain Capital announced that it has reached a definitive agreement with Aurobindo Pharma to acquire Natrol and combine it with Jarrow Formulas, another New Mountain Capital portfolio company. The transaction is expected to close by January 2021 subject to customary closing conditions and regulatory approvals.